We have previously reported that in vivo de-polymerization of F-actin filaments induces acute and chronic seizures in mice and rats. On these basis, we have investigated the effect of latrunculin A microdialysis in the mice hippocampus on seizure patterns, F-actin filaments and NMDA receptors. Latrunculin A (8 g/ml) was perfused for three consecutive days into the mice hippocampus using microdialysis probes with continuous EEG and video monitoring. After microdialysis experiments, F-actin depolymerization and synaptic and extrasynaptic NR1 protein levels were investigated. Intrahippocampal latrunculin A microperfusion induced partial seizures during the third day of perfusion, and the animals started showing spontaneous partial seizures one month after treatment. Increased levels of extracellular glutamate via microdialysis probes induced seizures in pre-treated mice. F-actin levels were significantly decreased, while NMDA receptor density increased both in synaptic and non-synaptic locations. These results support the hypothesis that actin disruption might be not just a consequence but also a possible cause of epileptic seizures. Actin depolymerization-induced seizures are related to an increase in synaptic and extrasynaptic NMDA receptors and to changes in the extracellular environment. We propose a new experimental model of epilepsy in mice which has been shown to be useful in the study of the biochemical changes that may lead to chronic seizures, and a new method for testing the efficacy of novel antiepileptic drugs in chronic animals.
Introduction
Much research has been done on the role of pre-and post-synaptic proteins in the pathogenesis of epilepsy but, until recently, relatively little attention has been given to the role of the F-actin cytoskeleton [1] . F-actin, a cytoskeletal protein that is concentrated in dendritic spines [2] , provides the main structural basis for their cytoskeletal organization. [2, 3] The F-actin cytoskeleton might be involved in epileptogenesis in two ways: Firstly, it is vulnerable to disruption through the N-methyl-D-aspartate receptor-Ca 2+ (NMDAR-Ca 2+ ) transduction pathways, inducing long-lasting plasticity changes that lead to recurrent epileptiform discharges [4.5] . Secondly, the disruption of actin
RESEARCH HIGHLIGHT
dynamics affects many proteins [6] , as well as to the shape of main synaptic structures such as dendritic spines [7] . As a consequence, disruption of actin dynamics has been hypothesized to play a key role in the pathogenesis of epilepsy [1, 8, 9, 10] . F-actin may be responsible for targeting NMDA receptors to synaptic sites [11, 12, 13] . The formation of glutamate receptor clusters in dendritic spines is determined by excitatory synaptic activity [14] . Interactions between the intracellular domains of NMDA receptors, several cytoskeletal elements and submembrane proteins of the postsynaptic density are essential for receptor location dynamics. [11] The actin cytoskeleton is also likely to play a role in the regulation of amino acid neurotransmitter extracellular concentrations by modifying uptake and release by both neurons and glia [15, 16, 17] . The synaptic vesicle cycle appears to be influenced by the actin cytoskeleton, [15] which also regulates the availability of the reserve synaptic vesicle pool, affects synapstic vesicle exocytosis and it's required for clathrin-mediated endocytosis [18] . A direct regulation of neurotransmitter release by actin is supported by strong experimental evidence in cultured neurons. [15] Moreover, it has been reported that actin dynamics may affect the brain extracellular amino acid concentrations by regulating the action of both glial and neuronal transporters. [16] Actin-binding drugs are a useful tool to investigate cytoskeleton-related subcellular processes. [6] Among them, latrunculin-A affects actin polymerization by the formation of a 1:1 molar complex with G-actin, causing net actin depolymerization. [19] Latrunculin-A has been widely used to study the role of F-actin in anchoring NMDARs to synaptic sites. [2, 11, 13] Latrunculin A treatment has been shown to promote neurotransmitter release in hippocampal synapses, as demonstrated by a significant increase in the frequency and size excitatory postsynaptic currents. [18] We have previously reported that latrunculin A microdialysis in the rat hippocampus induces epileptic seizures and long-term changes in neuronal excitability leading to the late onset of sporadic spontaneous seizures [8] .
The rats treated with intrahippocampal latrunculin A show also a long-term decrease of picrotoxin seizure threshold [8] , several changes in extracellular amino acid neurotransmitter concentrations, [17] and they are highly susceptible to the epileptogenic action of increased concentrations of glutamate and glycine. [20] Latrunculin A-induced seizures, as well as neurochemical changes associated to them can be prevented by antiepileptic drugs. [21, 22] In the present study we investigated the effect of F-actin depolymerization in the mouse hippocampus on seizure activity and NMDA receptor location. Our results suggest that actin disruption might be not just a consequence but also a possible cause of epileptic seizures. Our new experimental model in mice has shown to be useful to investigate the molecular changes that may lead to chronic seizures, and as a new method for testing antiepileptic drugs [21, 22] .
METHODS
Microdialysis methods have been described elsewhere in detail [17, 21] . Adult male Swiss mice, weighing 35-40 g were used. Before starting the experiments they were housed in individual cages under controlled environmental conditions (ambient temperature 21±1.8 °C, humidity 50-60%, 12:12 h light/dark cycle) with free access to food and water except during testing. Mice were obtained from the animalary of the University of Santiago. All experiments were performed in a laboratory with controlled environmental conditions and at the same time in the morning to avoid circadian variations. All efforts were made to minimize animal suffering, and our chronic animal protocols were designed to reduce the number of animals used. Animal care followed Spanish legislation on Protection of Animals Used in Experimental and Other Scientific Purposes, in agreement with the European Union regulations (O.J. of E.C. L358/1 18/12/1986) Mice were anaesthetized with sodium pentobarbital (50 mg/kg) and placed in a stereotaxic instrument (D. Kopf, Tujunga, CA, USA). Under aseptic conditions, three stainless steel microscrew electrodes were positioned in the skull; one above the frontal area one above the occipital area of each hemisphere; another screw, used as a reference electrode, was anchored in the mid-line, 2-3 mm rostrally to the coronal suture. The intracerebral guide for the microdialysis probe (CMA/10, CMA/Microdialysis AB, Stockholm, Sweden) was implanted vertically into the ventral hippocampus. Stereotaxis coordinates derived from the atlas of Paxinos and Franklin [23] were 3 mm posterior, 2.6 mm lateral and 2 mm ventral for the tip of the cannula relative to bregma and dural surface.
Wires from the microscrews were soldered to a miniature plug (Cannon MD1-9SL1, ITT Cannon, Santa Ana, USA) and fixed firmly to the skull with dental cement. After surgery, the mice were housed in individual cages and received antibiotic therapy for 2-3 days.
The experiments were carried out on conscious, freely moving mice, starting ten days after surgery. From the fourth day the animals were placed daily for three hours in the experimental unit for habituation. Bipolar cortical EEGs were recorded using a digital EEG system (MaxG, Zamora, Spain).
We used CMA/120 system for freely moving animals (CMA/Microdialysis AB, Stockholm, Sweden) and CMA/10 microdialysis probes with 2 mm of membrane length. The probe was connected via polyethylene tubing to a syringe selector (CMA/111), and to 1 ml syringes mounted on a microinjection pump (CMA/100). Before starting each experiment, the probe was perfused with ethanol and distilled water. After checking the integrity of the probe under a light microscope, it was perfused with vehicle solution for 10 min, tested routinely for in vitro recovery before every experiment and then introduced into the mouse hippocampus through the chronically implanted intracerebral guide.
We perfused latrunculin-A for a selective actin depolymerization [11] . For the control experiments, vehicle consisting in modified Ringer's solution containing 1:9375 ethanol was perfused at a constant flow rate of 1 l/min during 8 hours for three consecutive days. One week after controls, the same mice were perfused with latrunculin A (8 g/ml) fol lowing the same protocol. [8] One month after latrunculin A administration, all the animals were perfused during 8 hours with vehicle, and a group of six animals was perfused during three hours with 1mM glutamate dissolved in Ringer solution.
At the end of the experiments mice were anaesthetized with sodium pentobarbital and killed by decapitation. Then, the brain was removed and freezed to -40ºC.
Brains from adult swiss mice were quickly frozen and the cerebral hemispheres were separated and homogenized on ice in eight volumes of 0.32 M sucrose containing 4 mM HEPES and a protease and phosphatase inhibitor cocktail, pH 7.4 (buffer 1) using a Potter-Elvehjem Teflon-glass device. Subcellular fractionation, all steps at 4ºC, was performed according to the procedure described by Robinson et.al. [24] , with slight modifications. Briefly, supernatants of the 800 x g for 15 min centrifugation were centrifuged at 9200 x g for 15 min. The supernatants were ultracentrifuged at 100,000 x g for 90 min to obtain the cytosolic fraction in the supernatant and microsomal membranes in the pellet both stored at -80ºC .Pellets from this 9,200 x g centrifugation were resuspended in eight volumes of buffer1 and centrifuged again at 10,200 x g for 15min, the pellet (crude synaptosomes) was resuspended in four volumes of 20mM HEPES/NaOH, pH 8.0, 0.1M NaCl, 5 mM EDTA, 1% Triton X-100 and protease and phosphatase inhibitor cocktail (buffer 2) , incubated on ice for 30 min and ultacentrifuged at 100,000g x 30min.The supernatant (synaptosomal membranes,s1) was stored ay -80ºC, and the detergent-insoluble pellet (PSD-enriched fraction) was resuspended once more on the same volume of buffer 2 but also containing 0,5% Deoxycholate and, after being incubated 30min on ice, microcentrifuged 13,200 x g for15 min. Supernatants (PSD fraction, p1) and pellets of this centrifugation (insoluble synaptosomal membranes) was stored at -80ºC.
For EEG record data, including spike and wave discharges duration, seizure duration, and number of seizures were evaluated using the Medilog 9200 software, version 7.2. Statistical significance of the difference in number of seizures, seizure duration, and seizure onset times was determined by Student's paired t test. Statistical differences between Western-blot assays were determined by Student's paired t test.
RESULTS
Latrunculin-A induced a short-term increase on neuronal excitability in the mouse hippocampus leading to epileptiform seizures in 100 % of the animals studied. The severity, duration and onset time of the seizures showed considerable variation among animals, but all the seizures were observed during the third day of consecutive perfusion ( Fig 1A) . No behavioural or electroencephalographic effects were observed when vehicle was perfused or during the first day of latrunculin A perfusion (Fig 1 A, C, D) . During the second day of perfusion, slow waves without behavioural correlates were observed (Fig 1A) . During the third day, slow wave activity was increased, and frequent focal spike and spike-and wave discharges in the right hemisphere were recorded prior to the seizure onset (Fig 1 A, E, F, G) . Most seizures appeared unexpectedly at any time of the third day of perfusion without observable convulsions or behavioural signs of excitation althoug some seizures were accompanied by arrest-like behaviour, rearing or tonic convulsions. As previously reported [22] , EEG recordings during the month month following latrunculin A perfusion showed frequent slow wave activity with sporadic focal discharges and spike and wave bilateral discharges without observable behavioural signs.
After three days of in vivo microperfusion of latrunculin A in the mice hippocampus (8 hours a day) a significant loss in actin filaments was observed , both in the cytosolic fractions (62% of control, p<0.01) and at postsynaptic sites (26% of control, p<0.01). Actin depolymerization induced a long-term significant increase in NMDA receptors both at synaptic (163% of control, p<0.01) and extrasynaptic locations (174% of control, p<0.01) (Fig 1 B) .
Microperfusion of 1mM glutamate did not induce EEG discharges of behavioural changes in control mice. However, the same glutamate concentration perfused during three hours induced seizures in the 100% of the latrunculin A pre-treated animals (Fig 1 H) . Eventhough in the 60% of the animals electrographic bilateral seizures with no behavioural signs were observed, tonic-clonic seizures appeared in the 40% of the animals.
Discussion
In the past decades, a great number of animal models of epilepsy have been developed and used in many research studies designed to increase our understanding of the molecular abnormalities underlying neuronal hyperexcitability and seizure onset [25] . However, the need for new experimental models of chronic epilepsy, and for integrating existing models into the process of therapy discovery has been repeatedly pointed out [25, 26] . Latrunculin A microperfusion in the rat hippocampus has shown to be an effective model of acute and chronic seizures both for neurochemical studies [17] and for testing novel anticonvulsant drugs [21] . Moreover, latrunculin A microperfusion may be a useful alternative model for studying epileptogenic processes, as seizures are not the consequence of a previous status epilepticus. For this reason, we found interesting to extend this model to other species currently used for basic epilepsy research. We decided to study the effect of latrunculin A in mice because the mouse is involved in many genetic and transgenic models of neurological disorders.
Previous studies had shown that AMPA and NMDA receptors are anchored in the dendritic spines by actin cytoskeleton [2, 11] , and several findings support the use of latrunculin-A to perturb NMDA receptor clusters. [11, 13] We have previously reported that actin disrupting agents can be perfused in conscious, freely moving animals in order to investigate the in vivo effect of modifying actin dynamics, showing that latrunculin A modifies neuronal excitability in rats leading to both acute and chronic epileptic seizures. [9] However, the molecular mechanisms leading to latrunculin A-induced epileptogenesis are still unclear.
We show here for the first time that in vivo microperfusion of latrunculin A in mice induces a pattern of filamentous actin depolymerization which is very similar to the previously observed in cultured neurons [2, 11] . Previous results [22] indicate that F-actin depolymerization induces acute modifications on amino acid extracellular concentrations, and we show here that it also permanently affects NMDA receptor density and location in living mice. These results are consistent with our observations in rats. [27] Taken together with the effect of the increase in extracellular glutamate concentrations on latrunculin A pre-treated mice reported here and the previously reported results in rats [20] , they suggest that actin depolymerization might be not only a consequence but also a cause of epileptic seizures.
Reorganization and relocation of glutamate receptor channels is one of the possible molecular nechanisms underlying latrunculin A-induced seizures. F-actin depolymerization might lead to either receptor mobility along the membrane, or to receptor internalization and proteolysis. Newly synthetized receptors, probably assembled with different subunit compositions, might be transported to the cell membrane under conditions of imprecise location control. [28] When glutamate extracellular concentrations are increased by glutamate microperfusion, those receptors could be easily activated, resulting in biochemical modifications leading to acute epileptic seizures. Actin filament depolymerization by latrunculin A may also alter other NMDA receptor properties, such as protein anchoring to intracellular domains, thus altering the signaling pathways activated by both synaptic and extrasynaptic receptors. [9] Alterations in several actin-related proteins, such as acidic calponin [29] and calpain [30] have been linked to epileptic seizures in different experimental models. We have recently shown that latrunculin A microperfusion has a significant effect on components of the MAPK signaling pathways such as ERK 1/2 and pp38 [27] . Substantial evidence suggests the involvement of actin cytoskeleton in the excitability upregulation of postsynaptic neurons resulting from an increase in glutamate excitatory action [31] . Excitatory synaptic activity, involving calcium-mediated actin depolymerization [2, 32] and rapid dendritic spine plasticity [33, 34] , modulates AMPA and NMDA receptor redistribution in postsynaptic sites. This receptor redistribution plays an essential role in physiological phenomena such as long-term potentiation [32] as well as in pathological processes that might lead to epileptogenesis. [35, 36] Although most of the previous studies have been focused on receptor density variations, receptor subcellular localization has been shown to be an essential factor in modulating neuronal excitability [36] . Alterations in both receptor density and/or distribution on synaptic and extrasynaptic dendritic segments could be expected to modify the effectiveness of synaptic transmission. Furthermore, alterations in the distribution of recurrent excitatory synapses could lead to an enhanced ability to produce action potentials and, in turn, promote the reverberation of recurrent excitation in networks of mutually excitatory neurons. When changes such as an increase in a neurotransmitter extracellular concentration occurr in the extracellular environment, a greater number of active extrasynaptic receptors would make the neural assemblies more easily excitable and synchronizable. Although several recent investigations performed in cell cultures have shown that cell death could be mediated by extrasynaptic NMDA receptor activation [37] , we have not observed evidence of in vivo excitotoxicity or neuronal death following the activation of extrasynaptic NMDA receptors.
A role for the extrasynaptic NMDA-induced cell death in the pathogenesis of epilepsy cannot be ruled out, but an effect of synaptic/extrasynaptic imbalance on neural networks excitability seems more plausible. The result of three main features of refractary and post-traumatic epilepsies -neuronal loss, dendritic abnormalities, and gliosis-may be a net decrease in synaptic transmission through the affected networks, together with an increse of extrasynaptic signals from astrocytes [38, 39] that may, in turn, favor the anchoring of new NMDA receptors to extrasynaptic sites [9] . In summary, our results indicate that the in vivo neurochemical investigation of actin-dependent processes is required to fully understand the receptor and intracellular signaling dynamics, and it seems to be a promising approach to the neuropathology and neuropharmacology of the epilepsies.
